We’re done

Quote


















The clinical success rate of phase 2 trials (which is what that drug they acquired from fandango, or was it cobangahoe, will need to go through) is around 30%. They have a 70% probability of failing on their first go around, and a smaller cash runway than iwicki’s dick. So how will they recover if they initially fail on the pre-clinical side? Let’s say they succeed and get that me-too, orphan-drug to market. Why would anyone think the existing team would be successful in commercializing it?

I’d say we have a greater chance of a getting a year long severance than Kala ever has at being successful.
 






The clinical success rate of phase 2 trials (which is what that drug they acquired from fandango, or was it cobangahoe, will need to go through) is around 30%. They have a 70% probability of failing on their first go around, and a smaller cash runway than iwicki’s dick. So how will they recover if they initially fail on the pre-clinical side? Let’s say they succeed and get that me-too, orphan-drug to market. Why would anyone think the existing team would be successful in commercializing it?

I’d say we have a greater chance of a getting a year long severance than Kala ever has at being successful.
 






Agreed, they sold Eysuvius and Inveltys for less than the cost of the trials.
anonymous said:
The clinical success rate of phase 2 trials (which is what that drug they acquired from fandango, or was it cobangahoe, will need to go through) is around 30%. They have a 70% probability of failing on their first go around, and a smaller cash runway than iwicki’s dick. So how will they recover if they initially fail on the pre-clinical side? Let’s say they succeed and get that me-too, orphan-drug to market. Why would anyone think the existing team would be successful in commercializing it?

I’d say we have a greater chance of a getting a year long severance than Kala ever has at being successful.
Click to expand...
 
























The fact that Kevan was noticeably absent on that conference call speaks volumes. Especially after that BS email he sent out in the morning. So over this company and his fake cheerleader nonsense. I will be working as little as possible and trying to find myself a new job asap as all of us should be. They will give us as little as possible on the way out the door why should we give them anymore than what they give us.
 
























anonymous said:
The fact that Kevan was noticeably absent on that conference call speaks volumes. Especially after that BS email he sent out in the morning. So over this company and his fake cheerleader nonsense. I will be working as little as possible and trying to find myself a new job asap as all of us should be. They will give us as little as possible on the way out the door why should we give them anymore than what they give us.
Click to expand...
Maybe Iwicki gave him a swift kick in the ass and sent him packing. Well deserved walk of shame for that idiot
 






























I have to believe there will be investigations. And how would these people ever be able to raise money again? They will take the 60 million from Alcon for the products and bleed it into overhead and salaries and investors will get nothing.
 












Top Bottom
Back
Quote